Fractalkine (CX3CL1) and CX3CR1 pathway modulators
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fractalkine (CX3CL1) and CX3CR1 pathway modulators, covering 2024-11-12 to 2024-11-12. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Fractalkine and Its Receptor in Peri-implantitis [NA]